Physician profile
Kyle Robert Sweeney
NPI 1013208305
$8,539.67
in general payments reported to CMS, 2019-2025
12 companies · $619 in 2025
The $619 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,272 · 2020: $819 · 2021: $412 · 2022: $3,090 · 2023: $602 · 2024: $725 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,064.95 | 2019-2025 | Mako, Accolade, Gamma |
| Orthopediatrics Corp. | $2,700.00 | 2022 | |
| Smith+Nephew, INC. | $956.88 | 2019-2023 | Real Intelligence |
| Onkos Surgical, INC. | $268.16 | 2021-2023 | Eleos Limb Salvage System |
| Bone Support INC. | $266.04 | 2019-2020 | |
| Innovation Technologies INC | $126.91 | 2020 | |
| Exactech, INC. | $90.02 | 2020 | |
| Allergan, INC. | $17.92 | 2020 | |
| Osiris Therapeutics INC. | $14.49 | 2019 | |
| Heron Therapeutics, INC. | $13.51 | 2024 | Zynrelef |
| Daiichi Sankyo INC. | $12.19 | 2019 | |
| Illuminoss Medical, INC. | $8.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.